- Published on 15 October 2015
More than 90 prominent professionals representing 23 countries participated in Oticon Medical’s fourth annual scientific meeting held at Oticon Medical headquarters in Copenhagen from September 13 to 15. The three-day conference combined scientific presentations, lectures and roundtable discussions with more focused programs concentrating on audiology and surgery.
In the opening session, participants were introduced to the Neuro System, the first cochlear implant system from Oticon Medical. Professor Christophe Vincent, head of the ENT, Head and Neck Surgery Department at Lille University Hospital, France, showed the surgical procedure and intraoperative measures and shared first surgical impressions.
Robert Stokroos, MD, PhD of the Cochlear/Auditory Brainstem Implant team Zuid Oost Nederland, shared findings of the first randomized control clinical trial of the Minimally Invasive Ponto Surgery (MIPS).Bo Håkansson, PhD, Professor at Chalmers University of Technology, Gothenburg, Sweden, presented an update on an ongoing clinical study of the Bone Conduction Implant (BCI). Ida Institute Learning Specialist Ena Nielsen, PhD discussed the “Successes, Gaps ad Challenges in CI Rehabilitation” as they relate to children and their families on the cochlear implant journey.Hands-on demonstrations of the MIPS surgery technique and CI insertion with the Oticon Medical Neuro Zti rounded out the day for the surgeons.
The Audiological Session approached advances in bone anchored and cochlear implants from the audiologist’s perspective. The implications of skin drive and direct drive bone anchored solutions on speech intelligibility, sound quality and audibility were discussed by Darren Whelan, MSc of South Tees Hospital NHS Foundation Trust. Ad Snik, PhD of Donders Center for Brain, Cognition and Behavior, RadboudUMC, The Netherlands, explored factors that impact choice of the best intervention for a patient with conductive or mixed hearing loss including patient’s hearing loss, progression, anatomical and medical condition and preferences. Kari Morgenstein, AuD, F-AAA, University of Miami Ear Institute, discussed the current management of children with single-sided deafness (SSD) and presented protocols in place at the University of Miami Ear Institute’s pediatric SSD clinic. Preliminary results of an ongoing study of “Auditory Verbal Therapy” were presented by Lone Percy-Smith, MA, Rigshospitalet, University of Copenhagen. In her presentation of “Personalized Long-Term Follow-Up of Cochlear Implant Patients Using Remote Care”, Helen Cullington, PhD of the University of Southampton, UK described a long-term follow-up pathway for cochlear implant patients that offered them remote self-monitoring, self-adjustment of devices, and a personalized online or smartphone intervention package for testing their own hearing at home. Ricardo Bento, MD, PhD of the School of Medicine at the University of São Paulo, Brazil discussed recent advances in cochlear implant technology that focus on the preservation of residual hearing and electroacoustic stimulation (EAS).
“Oticon Medical has set an ambitious goal for the future: To become the world’s leading hearing expert in implantable hearing solutions,” said Oticon Medical President Jes Olsen. “With that ambition comes a responsibility not only to patients but also to support the surgeons and audiologists who are so essential to creating lifelong patient outcomes. Through our annual Scientific Meeting and other professional forums, we aim to stimulate knowledge-sharing that will enable clinicians to acquire new competencies, skills and theoretical foundations that have the potential to increase patient acceptance and satisfaction now and in the future.”
Source: Oticon Medical